Literature DB >> 26686687

Survival regulation of leukemia stem cells.

Yiguo Hu1, Shaoguang Li2.   

Abstract

Leukemia stem cells (LSCs) are a subpopulation cells at the apex of hierarchies in leukemia cells and responsible for disease continuous propagation. In this article, we discuss some cellular and molecular components, which are critical for LSC survival. These components include intrinsic signaling pathways and extrinsic microenvironments. The intrinsic signaling pathways to be discussed include Wnt/β-catenin signaling, Hox genes, Hh pathway, Alox5, and some miRNAs, which have been shown to play important roles in regulating LSC survival and proliferation. The extrinsic components to be discussed include selectins, CXCL12/CXCR4, and CD44, which involve in LSC homing, survival, and proliferation by affecting bone marrow microenvironment. Potential strategies for eradicating LSCs will also discuss.

Entities:  

Keywords:  AML; Alox5; CML; Hh; Hox; LSC; Microenvironment; Wnt; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26686687     DOI: 10.1007/s00018-015-2108-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  119 in total

Review 1.  WNT signalling and haematopoiesis: a WNT-WNT situation.

Authors:  Frank J T Staal; Hans C Clevers
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

2.  Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

Authors:  Marina Konopleva; Rooha Contractor; Twee Tsao; Ismael Samudio; Peter P Ruvolo; Shinichi Kitada; Xingming Deng; Dayong Zhai; Yue-Xi Shi; Thomas Sneed; Monique Verhaegen; Maria Soengas; Vivian R Ruvolo; Teresa McQueen; Wendy D Schober; Julie C Watt; Tilahun Jiffar; Xiaoyang Ling; Frank C Marini; David Harris; Martin Dietrich; Zeev Estrov; James McCubrey; W Stratford May; John C Reed; Michael Andreeff
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

3.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.

Authors:  Nicolas Pineault; Cheryl D Helgason; H Jeffrey Lawrence; R Keith Humphries
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

Review 4.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

5.  Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.

Authors:  James Kim; Blake T Aftab; Jean Y Tang; Daniel Kim; Alex H Lee; Melika Rezaee; Jynho Kim; Baozhi Chen; Emily M King; Alexandra Borodovsky; Gregory J Riggins; Ervin H Epstein; Philip A Beachy; Charles M Rudin
Journal:  Cancer Cell       Date:  2013-01-03       Impact factor: 31.743

6.  Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation.

Authors:  G Sauvageau; U Thorsteinsdottir; M R Hough; P Hugo; H J Lawrence; C Largman; R K Humphries
Journal:  Immunity       Date:  1997-01       Impact factor: 31.745

7.  Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.

Authors:  W Eisterer; X Jiang; O Christ; H Glimm; K H Lee; E Pang; K Lambie; G Shaw; T L Holyoake; A L Petzer; C Auewarakul; M J Barnett; C J Eaves; A C Eaves
Journal:  Leukemia       Date:  2005-03       Impact factor: 11.528

8.  Altered neural cell fates and medulloblastoma in mouse patched mutants.

Authors:  L V Goodrich; L Milenković; K M Higgins; M P Scott
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

9.  Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.

Authors:  Elizabeth A Griffiths; Steven D Gore; Craig Hooker; Michael A McDevitt; Judith E Karp; B Douglas Smith; Helai P Mohammad; Ying Ye; James G Herman; Hetty E Carraway
Journal:  Leuk Lymphoma       Date:  2010-09

10.  Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.

Authors:  Stefan Faderl; Guillermo Garcia-Manero; Deborah A Thomas; Hagop M Kantarjian
Journal:  Rev Clin Exp Hematol       Date:  2002-06
View more
  15 in total

1.  The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.

Authors:  Leisi Zhang; Yong Zhou; Kai Chen; Pengcheng Shi; Yin Li; Manman Deng; Zhiwu Jiang; Xiangmeng Wang; Peng Li; Bing Xu
Journal:  Target Oncol       Date:  2017-10       Impact factor: 4.493

2.  Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.

Authors:  A Etxabe; M C Lara-Castillo; J M Cornet-Masana; A Banús-Mulet; M Nomdedeu; M A Torrente; M Pratcorona; M Díaz-Beyá; J Esteve; R M Risueño
Journal:  Leukemia       Date:  2017-02-14       Impact factor: 11.528

Review 3.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

4.  Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal.

Authors:  Huihan Wang; Xiaobin Wang; Na Xin; Lin Qi; Aijun Liao; Wei Yang; Zhuogang Liu; Chenghai Zhao
Journal:  Mol Cell Biochem       Date:  2017-04-10       Impact factor: 3.396

5.  Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.

Authors:  Rupert L Mayer; Josef D Schwarzmeier; Marlene C Gerner; Andrea Bileck; Johanna C Mader; Samuel M Meier-Menches; Samuel M Gerner; Klaus G Schmetterer; Tobias Pukrop; Albrecht Reichle; Astrid Slany; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2017-12-01       Impact factor: 5.911

Review 6.  Cancer stem cell characteristics and their potential as therapeutic targets.

Authors:  Jacqueline R Lim; Josette Mouawad; Olivia K Gorton; William A Bubb; Ann H Kwan
Journal:  Med Oncol       Date:  2021-05-29       Impact factor: 3.064

7.  Ectopic Expression of Snail and Twist in Ph+ Leukemia Cells Upregulates CD44 Expression and Alters Their Differentiation Potential.

Authors:  Noa Kidan; Hazem Khamaisie; Nili Ruimi; Shay Roitman; Elizabeth Eshel; Najib Dally; Martin Ruthardt; Jamal Mahajna
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

8.  Yi-qi-yang-yin-tang increases the sensitivity of KG1a leukemia stem cells to daunorubicin by promoting cell cycle progression and regulating the expression of PTEN, TOPOII and mTOR.

Authors:  Zhe-Xin Shi; Hong-Yu Li; Xiang-Dong Yang; Hong Gao; De-Guan Li; Wen-Hua Yang; Fang Yao; Li-Xiang Yan
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

Review 9.  Aberrant Wnt Signaling in Leukemia.

Authors:  Frank J T Staal; Farbod Famili; Laura Garcia Perez; Karin Pike-Overzet
Journal:  Cancers (Basel)       Date:  2016-08-26       Impact factor: 6.639

10.  Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.

Authors:  Qing Ji; Ya-Hui Ding; Yue Sun; Yu Zhang; Hui-Er Gao; He-Nan Song; Ming Yang; Xiao-Lei Liu; Zi-Xiang Zhang; Ying-Hui Li; Ying-Dai Gao
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.